Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-11-14 9:00 pm Sale | 13G | Zymeworks Inc. ZYME | Redmile Group LLC | 5,101,911 7.200% | -688,319 (-11.89%) | View |
2024-11-14 4:27 pm Purchase | 13G | Zymeworks Inc. ZYME | BIOTECHNOLOGY VALUE FUND L P | 4,607,935 6.500% | 4,607,935 (New Position) | View |
2024-11-13 4:30 pm Purchase | 13G | Zymeworks Inc. ZYME | Rubric Capital Management LP | 3,917,331 5.510% | 3,917,331 (New Position) | View |
2024-02-22 7:01 pm Unchanged | 13D | Zymeworks Inc. ZYME | EcoR1 Capital LLC | 14,132,291 19.990% | 0 (Unchanged) | View |
2024-02-14 6:59 pm Purchase | 13G | Zymeworks Inc. ZYME | EcoR1 Capital LLC | 14,132,291 19.990% | 694,818 (+5.17%) | View |
2024-02-14 4:44 pm Sale | 13G | Zymeworks Inc. ZYME | PERCEPTIVE ADVISORS LLC | 1,074,807 1.500% | -3,436,468 (-76.18%) | View |
2024-02-14 4:26 pm Sale | 13G | Zymeworks Inc. ZYME | Redmile Group LLC | 5,790,230 8.300% | -385,688 (-6.25%) | View |
2024-02-14 4:21 pm Sale | 13G | Zymeworks Inc. ZYME | BAKER BROS. ADVISORS LP | 27,000 0.040% | -3,787,196 (-99.29%) | View |
2024-02-09 1:06 pm Sale | 13G | Zymeworks Inc. ZYME | MORGAN STANLEY MS | 4,842,464 6.900% | -736,916 (-13.21%) | View |
2024-01-29 5:25 pm Purchase | 13G | Zymeworks Inc. ZYME | BlackRock Inc. BLK | 3,923,328 5.600% | 3,923,328 (New Position) | View |
2023-06-21 4:05 pm Purchase | 13G | Zymeworks Inc. ZYME | EcoR1 Capital LLC | 13,437,473 19.900% | 5,868,900 (+77.54%) | View |
2023-02-14 4:29 pm Purchase | 13G | Zymeworks Inc. ZYME | Redmile Group LLC | 6,175,918 9.800% | 100,000 (+1.65%) | View |
2023-02-14 4:00 pm Purchase | 13G | Zymeworks Inc. ZYME | BAKER BROS. ADVISORS LP | 3,814,196 5.900% | 3,814,196 (New Position) | View |
2023-02-14 2:37 pm Sale | 13G | Zymeworks Inc. ZYME | EVENTIDE ASSET MANAGEMENT LLC | 0 0.000% | -2,819,135 (Position Closed) | View |
2023-02-14 2:31 pm Purchase | 13G | Zymeworks Inc. ZYME | PERCEPTIVE ADVISORS LLC | 4,511,275 7.200% | 4,511,275 (New Position) | View |
2023-02-10 5:28 pm Purchase | 13G | Zymeworks Inc. ZYME | GOLDMAN SACHS GROUP INC GS | 2,868,172 4.600% | 2,868,172 (New Position) | View |
2023-02-10 1:18 pm Purchase | 13G | Zymeworks Inc. ZYME | MORGAN STANLEY MS | 5,579,380 8.900% | 5,579,380 (New Position) | View |
2023-02-02 3:59 pm Purchase | 13G | Zymeworks Inc. ZYME | CREDIT SUISSE AG | 2,439,095 3.870% | 2,439,095 (New Position) | View |
2023-01-03 5:01 pm Purchase | 13G | Zymeworks Inc. ZYME | BIOTECHNOLOGY VALUE FUND L P | 5,870,000 9.300% | 5,870,000 (New Position) | View |
2022-12-28 4:35 pm Unchanged | 13D | Zymeworks Inc. ZYME | All Blue Falcons FZE | 2,786,936 4.420% | 0 (Unchanged) | View |